NasdaqGS - Nasdaq Real Time Price USD
Biomea Fusion, Inc. (BMEA)
1.9500
+0.2300
+(13.37%)
At close: April 22 at 4:00:02 PM EDT
1.9700
+0.02
+(1.03%)
After hours: April 22 at 7:45:19 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-119,894
-119,894
-96,592
-62,417
-35,438
Investing Cash Flow
-362
-362
-2,220
27,341
-33,355
Financing Cash Flow
1,668
1,668
163,798
1,239
153,185
End Cash Position
58,648
58,648
177,236
112,250
146,087
Capital Expenditure
-362
-362
-3,370
-1,030
-3,171
Issuance of Capital Stock
--
--
161,803
--
152,753
Free Cash Flow
-120,256
-120,256
-99,962
-63,447
-38,609
12/31/2021 - 4/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLT Applied Therapeutics, Inc.
0.3440
+3.43%
MIST Milestone Pharmaceuticals Inc.
1.0600
+4.95%
JUNS Jupiter Neurosciences, Inc.
0.6395
+3.06%
FDMT 4D Molecular Therapeutics, Inc.
3.4000
+10.39%
ANNX Annexon, Inc.
1.7600
+4.76%
CNTB Connect Biopharma Holdings Limited
0.6998
-6.31%
CHRS Coherus BioSciences, Inc.
1.0900
+2.83%
CCCC C4 Therapeutics, Inc.
1.5600
+11.43%
RGNX REGENXBIO Inc.
7.82
+17.24%
TPST Tempest Therapeutics, Inc.
7.58
+6.16%